Advertisement

Drugs & Aging

, Volume 28, Issue 10, pp 779–795 | Cite as

Arterial Aging

A Review of the Pathophysiology and Potential for Pharmacological Intervention
  • Michael F. O’Rourke
  • Audrey Adji
  • Mayooran Namasivayam
  • Jonathan Mok
Review Article

Abstract

This review begins with a perspective on the effects of arterial aging on society and world events over the past century. Until recently, the use of just one technique to measure blood pressure non-invasively limited progress in understanding the mechanisms involved and the potential of antihypertensive drug therapies. New methods for extracting information from the arterial waveform have followed the (re)introduction of arterial tonometry into clinical practice, together with mathematical analysis in the frequency and time domains. These new methods have exposed the phenomenon of aortic stiffening with age, and early wave reflection arising therefrom, and identified it as the major cause of cardiovascular degeneration. Such findings point to arterial aging as a logical target for the treatment and prevention not only of cardiac, aortic and large artery disease, but also of damage to microvessels in the brain and kidney, which in turn leads insidiously to dementia and renal failure, respectively.

Keywords

Pulse Wave Velocity Wave Reflection Arterial Aging Systolic Heart Failure Aortic Pulse Wave Velocity 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Notes

Acknowledgements

No sources of funding were used to assist in the preparation of this review. Michael O’Rourke is the founding director of AtCor, manufacturer of Pulse Wave Analysis System. The other authors have no conflicts of interest that are directly relevant to the content of this review.

References

  1. 1.
    Messerli FH. This day 50 years ago. N Engl J Med 1995; 332: 1038–9PubMedCrossRefGoogle Scholar
  2. 2.
    Pickering G. High blood pressure. 2nd ed. London: J & A Churchill, 1968Google Scholar
  3. 3.
    Cushing H. Concerning a definite regulatory mechanism of the vaso-motor centre which controls blood pressure during cerebral compression. Bull Johns Hopkins Hosp 1901; 12: 290–2Google Scholar
  4. 4.
    Smirk FH. High arterial pressure. Oxford: Blackwell, 1957Google Scholar
  5. 5.
    Laragh JH, Brenner BM, editors. Hypertension: pathophysiology, diagnosis and management. New York: Raven Press, 1995Google Scholar
  6. 6.
    Byrom FB, Wilson C. A plethysmographic method for measuring systolic blood pressure in the intact rat. J Physiol 1938; 93: 301–4PubMedGoogle Scholar
  7. 7.
    Byrom FB, Dodson LF. The causation of acute arterial necrosis in hypertensive disease. J Pathol Bacteriol 1948; 60: 357–68CrossRefGoogle Scholar
  8. 8.
    Byrom FB. The hypertensive vascular crisis: an experimental study. London: Heinemann, 1969Google Scholar
  9. 9.
    Kaplan NM. Clinical hypertension. 5th ed. Baltimore (MD): Williams &Wilkins, 1990Google Scholar
  10. 10.
    Ledingham JM. The vascular fault in hypertension: Byrom’s work revisited. In: Laragh JH, Brenner BM, editors. Hypertension: pathophysiology, diagnosis and management. New York: Raven Press, 1995; 37–53Google Scholar
  11. 11.
    VA Cooperative Study Group. Effects of treatment on morbidity in hypertension: results in patients with diastolic blood pressures averaging 115 through 129 mm Hg. JAMA 1967; 202: 1028–34CrossRefGoogle Scholar
  12. 12.
    VA Cooperative Study Group. Effects of treatment on morbidity in hypertension, II: results in patients with diastolic blood pressure averaging 90 through 114 mm Hg. JAMA 1970; 213: 1143–52CrossRefGoogle Scholar
  13. 13.
    Systolic Hypertension in Elderly Program Cooperative Research Group (SHEP). Implications of the systolic hypertension in the elderly program. Hypertension 1993; 21: 335–43CrossRefGoogle Scholar
  14. 14.
    O’Rourke MF, Kelly RP, Avolio AP, et al. Effects of arterial dilator agents on central aortic systolic pressure and on left ventricular hydraulic load. Am J Cardiol 1989; 63: 381–441Google Scholar
  15. 15.
    Dustan HP. Isolated systolic hypertension: a long-neglected cause of cardiovascular complications. Am J Med 1989; 86: 358–69CrossRefGoogle Scholar
  16. 16.
    Levy D, Brink S. A change in heart. New York: Vintage Books, 2005Google Scholar
  17. 17.
    Franklin SS, Gustin 4th W, Wong ND, et al. Hemodynamic patterns of age-related changes in blood pressure. Circulation 1997; 96: 308–15PubMedCrossRefGoogle Scholar
  18. 18.
    Franklin SS, Khan SA, Wong ND, et al. Is pulse pressure useful in predicting risk for coronary heart disease? Circulation 1999; 100: 354–60PubMedCrossRefGoogle Scholar
  19. 19.
    Kannel WB, Wolf PA, McGee DL, et al. Systolic blood pressure, arterial rigidity and risk of stroke. JAMA 1981; 245: 1225–9PubMedCrossRefGoogle Scholar
  20. 20.
    Nichols WW, O’Rourke MF, Vlachopoulos C. McDonald’s blood flow in arteries. 6th ed. London: Hodder Arnold, 2011Google Scholar
  21. 21.
    Laurent S, Cockcroft J, Van Bortel L, et al., on behalf of the European Network for Non-invasive Investigation of Large Arteries. Expert consensus document on arterial stiffness: methodological issues and clinical applications. Eur Heart J 2006; 27: 2588–605PubMedCrossRefGoogle Scholar
  22. 22.
    Namasivayam M, McDonnell BJ, McEniery CM, et al., on behalf of the Anglo-Cardiff Collaborative Trial Study Investigators. Does wave reflection dominate age-related change in aortic blood pressure across the human life span? Hypertension 2009; 53: 979–85PubMedCrossRefGoogle Scholar
  23. 23.
    Salvi P, Safar ME, Labat C, et al., PARTAGE Study Investigators. Heart disease and changes in pulse wave velocity and pulse pressure amplification in the elderly over 80 years: the PARTAGE Study. J Hypertens 2010; 28: 2127–33PubMedGoogle Scholar
  24. 24.
    O’Rourke MF, Hashimoto J. Mechanical factors in arterial aging. J Am Coll Cardiol 2007; 50: 1–13PubMedCrossRefGoogle Scholar
  25. 25.
    Lakatta EG, Levy D. Arterial and cardiac aging: major shareholders in cardiovascular disease enterprise, part I: aging arteries: a ‘set up’ for vascular disease. Circulation 2003; 107: 139–46PubMedCrossRefGoogle Scholar
  26. 26.
    Lakatta EG, Levy D. Arterial and cardiac aging: major shareholders in cardiovascular disease enterprise, part II: the aging heart in health: links to heart disease. Circulation 2003; 107: 346–54PubMedCrossRefGoogle Scholar
  27. 27.
    Avolio AP, Chen S, Wang R, et al. Effects of aging on changing arterial compliance and left ventricular load in a northern Chinese urban community. Circulation 1982; 68: 50–8CrossRefGoogle Scholar
  28. 28.
    Avolio AP, Deng FQ, Li WQ, et al. Effects of aging on arterial distensibility in populations with high and low prevalence of hypertension: comparison between urban and rural communities in China. Circulation 1985; 71: 202–10PubMedCrossRefGoogle Scholar
  29. 29.
    Lindley PB. Engineering design with natural rubber. Malaysian Rubber Fund Board. The Natural Rubber Producers Research Association Technical Bulletin, 4th ed., 1974; 8: 17–19Google Scholar
  30. 30.
    Fritze O, Schleicher M, König K, et al. Facilitated noninvasive visualization of collagen and elastin in blood vessels. Tissue Eng Part C Methods 2010; 16: 705–10PubMedCrossRefGoogle Scholar
  31. 31.
    Virmani R, Avolio AP, Mergner WJ, et al. Effect of aging on aortic morphology in populations with high and low prevalence of hypertension and atherosclerosis: comparison between occidental and Chinese communities. Am J Pathol 1991; 139: 1119–29PubMedGoogle Scholar
  32. 32.
    Virmani R, Kolodgie FD, Burke AP, et al. Atherosclerotic plaque progression and vulnerability to rupture: angiogenesis as a source of intraplaque hemorrhage. Arterioscler Thromb Vasc Biol 2005; 25: 2054–61PubMedCrossRefGoogle Scholar
  33. 33.
    Safar ME, O’Rourke MF. Arterial stiffness in hypertension. In: Birkenhager WH, Reid JL, editors. Handbook of hypertension. No. 23. London: Elsevier, 2006Google Scholar
  34. 34.
    Redheuil A, Yu WC, Wu CO, et al. Reduced ascending aortic strain and distensibility: earliest manifestations of vascular aging in humans. Hypertension 2010; 55: 319–26PubMedCrossRefGoogle Scholar
  35. 35.
    Murgo JP, Westerhof N, Giolma JP, et al. Aortic input impedance in normal man: relationship to pressure wave forms. Circulation 1980; 62: 105–16PubMedCrossRefGoogle Scholar
  36. 36.
    Weber T, Auer J, O’Rourke MF, et al. Prolonged mechanical systole and increased arterial wave reflections in diastolic dysfunction. Heart 2006; 92: 1616–22PubMedCrossRefGoogle Scholar
  37. 37.
    Weber T, O’Rourke MF, Ammer M, et al. Arterial stiffness and arterial wave reflections are associated with systolic and diastolic function in patients with normal ejection fraction. Am J Hypertens 2008; 21: 1194–202PubMedCrossRefGoogle Scholar
  38. 38.
    de Simone G, Kitzman DW, Chinali M, et al. Left ventricular concentric geometry is associated with impaired relaxation in hypertension: the HyperGEN study. Eur Heart J 2005; 26: 1039–45PubMedCrossRefGoogle Scholar
  39. 39.
    Sugawara J, Hayashi K, Yokoi T, et al. Age-associated elongation of the ascending aorta in adults. JACC Cardiovasc Imaging 2008; 1: 739–48PubMedCrossRefGoogle Scholar
  40. 40.
    Weber T, O’Rourke MF, Lassnig E, et al. Pulse waveform characteristics predict cardiovascular events and mortality in patients undergoing coronary angiography. J Hypertens 2010; 28: 797–805PubMedCrossRefGoogle Scholar
  41. 41.
    Cullen KM, Kócsi Z, Stone J. Pericapillary haem-rich deposits: evidence for microhaemorrhages in aging human cerebral cortex. J Cereb Blood Flow Metab 2005; 25: 1656–67PubMedCrossRefGoogle Scholar
  42. 42.
    Cullen KM, Kocsi Z, Stone J. Microvascular pathology in the aging human brain: evidence that senile plaques are sites of microhaemorrhages. Neurobiol Aging 2006; 27: 1786–96PubMedCrossRefGoogle Scholar
  43. 43.
    Kearney-Schwartz A, Rossignol P, Bracard S, et al. Vascular structure and function is correlated to cognitive performance and white matter hyperintensities in older hypertensive patients with subjective memory complaints. Stroke 2010; 40: 1229–36CrossRefGoogle Scholar
  44. 44.
    O’Rourke MF, Safar ME. Relationship between aortic stiffening and microvascular disease in brain and kidney: cause and logic of therapy. Hypertension 2005; 46: 200–4PubMedCrossRefGoogle Scholar
  45. 45.
    Edwards JE. Functional pathology of the pulmonary vascular tree in congenital cardiac disease. Circulation 1957; 15: 164–96PubMedCrossRefGoogle Scholar
  46. 46.
    Kass DA, Shapiro EP, Kawaguchi M, et al. Improved arterial compliance by a novel advanced glycation end-product crosslink breaker. Circulation 2001; 104: 1464–70PubMedCrossRefGoogle Scholar
  47. 47.
    Mitchell GF, Izzo Jr JL, Lacourcière Y, et al. Omapatrilat reduces pulse pressure and proximal aortic stiffness in patients with systolic hypertension: results of the conduit hemodynamics of omapatrilat international research study. Circulation 2002; 105: 2955–61PubMedCrossRefGoogle Scholar
  48. 48.
    Iliopoulos J. The aortic wrap procedure: a surgical method of treating age related aortic dilatation and stiffening [dissertation]. Sydney (NSW): University of New South Wales, 2006Google Scholar
  49. 49.
    O’Rourke MF. Steady and pulsatile energy losses in the systemic circulation under normal conditions and in simulated arterial disease. Cardiovasc Res 1967; 1: 313–26PubMedCrossRefGoogle Scholar
  50. 50.
    O’Rourke MF. Arterial hemodynamics in hypertension. Circ Res 1970; 27Suppl. 2: 123–33PubMedGoogle Scholar
  51. 51.
    Asmar RG, London GM, O’Rourke MF, et al., for the REASON Project Coordinators and Investigators. Improvement in blood pressure, arterial stiffness and wave reflections with a very-low-dose perindopril/indapamide combination in hypertensive patients: a comparison with atenolol. Hypertension 2001; 38: 922–6PubMedCrossRefGoogle Scholar
  52. 52.
    Ait-Oufella H, Collin C, Bozec E, et al. Long-term reduction in aortic stiffness: a 5.3-year follow-up in routine clinical practice. J Hypertens 2010; 28: 2336–41PubMedCrossRefGoogle Scholar
  53. 53.
    Yaginuma T, Avolio AP, O’Rourke MF, et al. Effect of glyceryl trinitrate on peripheral arteries alters left ventricular hydraulic load in man. Cardiovasc Res 1986; 20: 153–60PubMedCrossRefGoogle Scholar
  54. 54.
    Murrell W. Nitroglycerin as a remedy for angina pectoris. Lancet 1879; 113: 80–1, 113–5, 151–2, 225–7CrossRefGoogle Scholar
  55. 55.
    O’Rourke MF, Safar ME, Dzau V, editors. Arterial vasodilation: mechanisms and therapy. London: Edward Arnold, 1993Google Scholar
  56. 56.
    Kelly RP, Gibbs HH, O’Rourke MF, et al. Nitroglycerin has more favourable effects on left ventricular afterload than apparent from measurement of pressure in a peripheral artery. Eur Heart J 1990; 11: 138–44PubMedGoogle Scholar
  57. 57.
    Takazawa K, Tanaka N, Takeda K, et al. Underestimation of vasodilator effects of nitroglycerin by upper limb blood pressure. Hypertension 1995; 26: 520–3PubMedCrossRefGoogle Scholar
  58. 58.
    Simkus GJ, Fitchett DH. Radial arterial pressure measurements may be a poor guide to the beneficial effects of nitroprusside on left ventricular systolic pressure in congestive heart failure. Am J Cardiol 1990; 66: 323–6PubMedCrossRefGoogle Scholar
  59. 59.
    London GM, Asmar RG, O’Rourke MF, et al., REASON Project Investigators. Mechanism(s) of selective systolic blood pressure reduction after a low-dose combination of perindopril/indapamide in hypertensive subjects: comparison with atenolol. J Am Coll Cardiol 2004; 43: 92–9PubMedCrossRefGoogle Scholar
  60. 60.
    Hirata K, Vlachopoulos C, Adji A, et al. Benefits from angiotensin-converting enzyme inhibitor ‘beyond blood pressure lowering’: beyond blood pressure or beyond the brachial artery? [published erratum appears in J Hypertens 2005; 23: 903–4]. J Hypertens 2005; 23: 551–6PubMedCrossRefGoogle Scholar
  61. 61.
    Williams B, Lacy PS, Thom SM, et al., the CAFE Investigators. Differential impact of blood pressure-lowering drugs on central aortic pressure and clinical outcomes. Circulation 2006; 113: 1213–25PubMedCrossRefGoogle Scholar
  62. 62.
    Jiang X-J, O’Rourke MF, Zhang Y-Q, et al. Superior effect of an angiotensin-converting enzyme inhibitor over a diuretic for reducing aortic systolic pressure. J Hypertens 2007; 25: 1095–9PubMedCrossRefGoogle Scholar
  63. 63.
    Matsui Y, Eguchi K, O’Rourke MF, et al. Differential effects between a calcium channel blocker and a diuretic when used in combination with angiotensin II receptor blocker on central aortic pressure in hypertensive patients. Hypertension 2009; 54: 716–23PubMedCrossRefGoogle Scholar
  64. 64.
    Merillon JP, Fontenier GJ, Lerallut JF, et al. Aortic input impedance in normal man and arterial hypertension: its modification during changes in aortic pressure. Cardiovasc Res 1982; 16: 646–56PubMedCrossRefGoogle Scholar
  65. 65.
    Merillon JP, Fontenier GJ, Lerallut JF. Aortic input impedance in heart failure: comparison with normal subjects and its changes during vasodilator therapy. Eur Heart J 1984; 5: 447–55PubMedGoogle Scholar
  66. 66.
    Laskey WK, Kussmaul WG, Martin JL, et al. Characteristics of vascular hydraulic load in patients with heart failure. Circulation 1985; 72: 61–71PubMedCrossRefGoogle Scholar
  67. 67.
    Ting CT, Choy CY, Chang MS, et al. Arterial hemodynamics in human hypertension: effects of adrenergic blockade. Circulation 1991; 84: 1049–57PubMedCrossRefGoogle Scholar
  68. 68.
    Ting CT, Yang TM, Chen JW, et al. Arterial hemodynamics in human hypertension: effects of angiotensin converting enzyme inhibition. Hypertension 1993; 22: 839–46PubMedCrossRefGoogle Scholar
  69. 69.
    Ting CT, Chen CH, Chang MS, et al. Arterial hemodynamics in human hypertension: effects of the calcium-channel antagonist nifedipine. Hypertension 1995; 25: 1326–32PubMedCrossRefGoogle Scholar
  70. 70.
    Noda T, Yaginuma T, O’Rourke MF, et al. Effects of nifedipine on systemic and pulmonary vascular impedance in subjects undergoing cardiac catheterization. Hypertens Res 2006; 29: 505–13PubMedCrossRefGoogle Scholar
  71. 71.
    Smirk FH, Alstad KS. Treatment of arterial hypertension by penta- and hexamethonium salts: based on 150 tests on hypertensives of varied aetiology and 53 patients treated for periods of two to fourteen months. BMJ 1951; 288: 1087–90Google Scholar
  72. 72.
    ALLHAT Collaborative Research Group. Major cardiovascular events in hypertensive patients randomized to doxazosin vs chlorthalidone: the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT) [published erratum appears in JAMA 2002; 288: 2976]. JAMA 2000; 283: 1967–75CrossRefGoogle Scholar
  73. 73.
    ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group (The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial). Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) [published errata appear in JAMA 2004; 291: 2196 and JAMA 2003; 289: 178]. JAMA 2002; 288: 2981–97CrossRefGoogle Scholar
  74. 74.
    Yusuf S, Slight P, Pogue J, et al., for the Heart Outcomes Prevention Evaluation (HOPE) Study Investigators. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. N Engl J Med 2000; 342: 145–53PubMedCrossRefGoogle Scholar
  75. 75.
    O’Rourke MF, Nichols WW. Effect of ramipril on cardiovascular events in high-risk patients. N Engl J Med 2000; 343: 64–6PubMedCrossRefGoogle Scholar
  76. 76.
    Dahlof B, Devereux R, Kjeldsen S, et al. Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE), a randomized trial against atenolol. Lancet 2002; 359: 995–1002PubMedCrossRefGoogle Scholar
  77. 77.
    de Luca N, Asmar RG, London GM, et al. Selective reduction of cardiac mass and central blood pressure following a low-dose combination of perindopril/indapamide in hypertensive subjects. J Hypertens 2004; 22: 1623–30PubMedCrossRefGoogle Scholar
  78. 78.
    Dahlof B, Sever PS, Poulter NR, et al., for the ASCOT Investigators. Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required vs atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomized controlled trial. Lancet 2005; 366: 895–906PubMedCrossRefGoogle Scholar
  79. 79.
    Jamerson K, Weber MA, Bakris GL, et al., ACCOMPLISH Trial Investigators. Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients. N Engl J Med 2008; 359: 2417–28PubMedCrossRefGoogle Scholar
  80. 80.
    Staessen JA, Richart T, Wang Z, et al. Implications of recently published trials of blood pressure lowering drugs in hypertensive or high-risk patients. Hypertension 2010; 55: 819–31PubMedCrossRefGoogle Scholar
  81. 81.
    Westerhof N, O’Rourke MF. Haemodynamic basis for the development of left ventricular failure in systolic hypertension and for its logical therapy. J Hypertens 1995; 13: 943–52PubMedCrossRefGoogle Scholar
  82. 82.
    O’Rourke MF, Lei J. Separation of systolic from diastolic dysfunction as a cause of cardiac failure by analysis of the arterial pulse wave [abstract]. Aust NZ J Med 1997;28: 114Google Scholar
  83. 83.
    Pauca AL, Kon ND, O’Rourke MF. Benefit of glyceryl trinitrate on arterial stiffness is directly due to effects on peripheral arteries. Heart 2005; 91: 1428–32PubMedCrossRefGoogle Scholar
  84. 84.
    Hirata K, O’Rourke MF, Momomura S. Effect of nitrate on the carotid late systolic flow augmentation-a new strategy against stroke. J Hypertens 2008; 25Suppl. 2: S336–7Google Scholar
  85. 85.
    Kelly RP, Tunin R, Kass DA. Effect of reduced aortic compliance on cardiac efficiency and contractile function of in situ canine left ventricle. Circ Res 1992; 71: 490–502PubMedCrossRefGoogle Scholar
  86. 86.
    Vita JA, Keaney Jr JF. Exercise: toning up the endothelium? N Engl J Med 2000; 342: 503–5PubMedCrossRefGoogle Scholar
  87. 87.
    Hayward CS, Kraidly M, Webb CM, et al. Assessment of endothelial function using peripheral waveform analysis: a clinical application. J Am Coll Cardiol 2002; 40: 521–8PubMedCrossRefGoogle Scholar
  88. 88.
    Wilkinson IB, Hall IR, MacCallum H, et al. Pulse wave analysis: clinical evaluation of a non-invasive, widely available method for assessing endothelial function. Arterioscler Thromb Vasc Biol 2002; 22: 147–52PubMedCrossRefGoogle Scholar
  89. 89.
    Edwards DG, Schofield RS, Lennon SL, et al. Effect of exercise training on endothelial function in men with coronary artery disease. Am J Cardiol 2004; 93: 617–20PubMedCrossRefGoogle Scholar
  90. 90.
    Mustata S, Chan C, Lai V, et al. Impact of an exercise program on arterial stiffness and insulin resistance in hemodialysis patients. J Am Soc Nephrol 2004; 15: 2713–8PubMedCrossRefGoogle Scholar

Copyright information

© Adis Data Information BV 2011

Authors and Affiliations

  • Michael F. O’Rourke
    • 1
    • 2
    • 3
  • Audrey Adji
    • 1
    • 4
  • Mayooran Namasivayam
    • 1
    • 2
  • Jonathan Mok
    • 1
  1. 1.Suite 810, St Vincent’s ClinicDarlinghurst, SydneyAustralia
  2. 2.University of New South WalesSydneyAustralia
  3. 3.Victor Chang Cardiac Research InstituteSydneyAustralia
  4. 4.Australian School of Advanced MedicineMacquarie UniversitySydneyAustralia

Personalised recommendations